Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4646-4653

  Ran, Sophia ^a,c   Gao, Boning ^a   Duffy, Steve ^a   Watkins, Linda ^a   Rote, Neal ^b   Thorpe, Philip E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CLOTTING; CANCER INHIBITION; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; PRIORITY JOURNAL; SCID MOUSE; SOLID TUMOR; TUMOR THROMBUS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; FACTOR V; HODGKIN DISEASE; HUMANS; MALE; MICE; MICE, SCID; PHOSPHATIDYLSERINES; RATS; THROMBOPLASTIN; THROMBOSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032532656     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Huang, X-, Molema, G., King, S., Watkins, L., Edgington, T. S., and Thorpe, P. E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (Washington DC), 275: 547-550, 1997.
2. Denekamp, J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis. Rev., 9: 267-282, 1990.
3. Ruf, W., Rehemtulla, A., and Edgington, T. S. Phospholipid-independent and dependent interactions required for tissue factor receptor and cofactor function. J. Biol. Chem., 266: 2158-2166, 1991.
4. Ruf, W., and Edgington, T. S. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J., 8: 385-390, 1994.
5. Stone, M. J., Ruf, W., Miles, D. J., Edgington, T. S., and Wright, P. E. Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from E. coli inclusion bodies: glycosylation of mutants, activity, and physical characterization. Biochem. J., 310: 605-614, 1995.
6. Nawroth, P., Handley, D., Matsueda, G., DeWaal, R., Gerlach, H., Blohm, D., and Stern, D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J. Exp. Med., 168: 637-647, 1988.
7. Zacharski, L. B., Memoli, V. A., Ornstein, D. L., Rousseau, S. M., Kisiel, W., and Kudryk, B. J. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J. Natl. Cancer Inst., 85: 1225-1230, 1993.
8. Patey, N., Vazeux, R., Canioni, D., Potter, T., Gallatin, W. M., and Brousse, N. Intercellular adhesion molecule-3 on endothelial cells: expression in tumors but not in inflammatory responses. Am. J. Pathol., 148: 465-472, 1996.
9. Droz, D., Patey, N., Paraf, F., Chretien, Y., and Gogusev, J. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab. Invest., 71: 710-718, 1994.
10. Staal-van den Brekel, A. J., Thunnissen, F. B. J. M., Buurman, W. A., and Wouters, E. F. M. Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma. Virchows Arch., 428: 21-27, 1996.
11. Kuzu, I., Bicknell, R., Fletcher, C. D. M., and Gatter, K. C. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab. Invest., 69: 322-328, 1993.
12. Bruijn, J. A., and Dinklo, N. J. C. M. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab. Invest., 69: 329-335, 1993.
13. Fries, J. W. U., Williams, A. J., Atkins, R. C., Newman, W., Lipscomb, M. F., and Collins, T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol., 143: 725-737, 1993.
14. Thornhill, M. H., Kyan-Aung, U., and Haskard, D. O. IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J. Immunol., 144: 3060-3065, 1990.
15. Munro, J. M. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur. Heart J., 14: 72-77, 1993.
16. Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 11: 767-804, 1993.
17. Diehl, V., Pfreundschuh, M., Fonatsch, C., Stein, H., Falk, M., Burrichter, H., and Schaadt, M. Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological, and clinical implications. Cancer Surv., 4: 399-416, 1985.
18. Rote, N. S., Ng, A-K., Dostal-Johnson, D. A., Nicholson, S. L., and Siekman, R. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin. Immunol. Immunopathol., 66: 193-200, 1993.
19. Miyake, K., Medina, K., Ishihara, K., Kimoto, M., Auerbach, R., and Kincade, W. A. VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell. Biol., 114: 557-565, 1991.
20. Morrissey, J. H., Fair, D. S., and Edgington, T. S. Monoclonal antibody analysis of purified, and cell-associated tissue factor. Thromb. Res., 52: 247-261, 1988.
21. Ge, A. Z., and Butcher, E. C. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligand. Gene (Amst.), 138: 201-206, 1994.
22. Leppink, D. M., Bishop, D. K., Sedmak, D. D., Henry, M. L., Ferguson, R. M., Streeter, P. R., Butcher, E. C., and Orosz, C. G. Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration. Transplantation (Baltimore), 48(5): 874-877, 1989.
23. Bussolino, F., deRossi, M., Sica, A., Colotta, F., Wang, J. M., Bocchietto, E., Martin Padura, I., Bosia, A., Dejana, E., and Mantovani, A. Murine endothelial cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J. Immunol., 147: 2122-2129, 1991.
24. Montesano, R., Pepper, M. S., Mohle-Steinlein, U., Risau, W., Wagner, E. F., and Orci, L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell, 62: 435-445, 1990.
25. Bocci, V. Efficient labeling of serum proteins with 131I using chloramine T. Int. J. Appl. Radiat. Isot., 15: 449-456, 1964.
26. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
27. Hahne, M., Jager, U., Isenmann, S., Hallmann, R., and Vestweber, D. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J. Cell Biol., 121: 655-664, 1993.
28. Schorer, A. E., Rick, P. D., Swaim, W. R., and Moldow, C. F. Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury. J. Lab. Clin. Med., 106: 38-42, 1985.
29. Nawroth, P. P., Stern, D. M., Kisiel, W., and Bach, R. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb. Res., 40: 677-691, 1985.
30. Burrows, F. J., Watanabe, Y., and Thorpe, P. E. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Cancer Res., 52: 5954-5962, 1992.
31. Gibbons, J. D. Mann-Whitney-Wilcoxon test for two independent samples. In: J. D. Gibbons (ed.), Nonparametric methods for quantitative analysis, pp. 160-161, New York: Holt, Rinehart and Winston, 1976.
32. Dachary-Prigent, J., Toti, F., Satta, N., Pasquet, J. M., Uzan, A., and Freyssinet, J. M. Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin. Thromb. Hemostasis, 22: 157-164, 1996.
33. Bevers, E. M., Rosing, J., and Zwaal, R. F. Development of procoagulant binding sites on the platelet surface. Adv. Exp. Med. Biol., 192: 359-371, 1985.
34. Ortel, T. L., Devore-Carter, D., Quinn-Allen, M., and Kane, W. H. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J. Biol. Chem., 267: 4189-4198, 1992.
35. Sluiter, W., Pietersma, A., Lamers, J. M. J., and Koster, J. F. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J. Cardiol. Pharmacol., 22: S37-S44, 1993.
36. Williamson, P., and Schlegel, R. A. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol. Membr. Biol., 11: 199-216, 1994.
37. Donati, M. B. Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Thromb. Haemost., 74: 278-281, 1995.
38. Julien, M., Tournier, J. F., and Tocanne, J. F. Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. Eur. J. Biochem., 230: 287-297, 1995.
39. Zhao, J., Zhou, Q., Wiedmer, T., and Sims, P. J. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem., 273: 6603-6606, 1998.
40. Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A., Navarro, V., Knudsen, B., and Bander, N. H. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res., 57: 3629-3634, 1997.